| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Manuel Mayr | Q37371734 |
| P2093 | author name string | Anna Zampetaki | |
| Peter Willeit | |||
| Ignat Drozdov | |||
| Stefan Kiechl | |||
| P2860 | cites work | Transfer of microRNAs by embryonic stem cell microvesicles | Q21143855 |
| Detection of microRNA expression in human peripheral blood microvesicles | Q21144210 | ||
| Serum microRNAs are promising novel biomarkers | Q21144238 | ||
| Geometric interpretation of gene coexpression network analysis | Q21145373 | ||
| Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery | Q21147047 | ||
| Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes | Q24537363 | ||
| miR-126 regulates angiogenic signaling and vascular integrity | Q24569770 | ||
| Secretory mechanisms and intercellular transfer of microRNAs in living cells | Q24603413 | ||
| Characterization of extracellular circulating microRNA | Q24603537 | ||
| Circulating microRNAs are new and sensitive biomarkers of myocardial infarction | Q24606701 | ||
| Secretory microRNAs as a versatile communication tool | Q24614401 | ||
| Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers | Q24614672 | ||
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| The impact of microRNAs on protein output | Q24653549 | ||
| Circulating microRNAs, potential biomarkers for drug-induced liver injury | Q24656209 | ||
| The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis | Q24656947 | ||
| Mammalian microRNAs predominantly act to decrease target mRNA levels | Q27860535 | ||
| Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells | Q27860960 | ||
| Network biology: understanding the cell's functional organization | Q27861027 | ||
| An efficient algorithm for large-scale detection of protein families | Q28131838 | ||
| Relief of microRNA-mediated translational repression in human cells subjected to stress | Q28246349 | ||
| Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction | Q28264011 | ||
| A translational study of circulating cell-free microRNA-1 in acute myocardial infarction | Q28275588 | ||
| A receptor for phosphatidylserine-specific clearance of apoptotic cells | Q28586441 | ||
| Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures | Q28743515 | ||
| Exosomes: composition, biogenesis and function | Q29547721 | ||
| Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma | Q29547772 | ||
| Export of microRNAs and microRNA-protective protein by mammalian cells | Q29614234 | ||
| MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins | Q29615034 | ||
| Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication | Q29615670 | ||
| The MicroRNA Spectrum in 12 Body Fluids | Q29618068 | ||
| Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. | Q54408211 | ||
| Circulating microRNAs in patients with coronary artery disease. | Q54421687 | ||
| MiR423-5p as a circulating biomarker for heart failure. | Q54439825 | ||
| Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: A potential predictor for the individual capacity to develop collaterals | Q73977699 | ||
| MicroRNAs as circulating biomarkers for heart failure: questions about MiR-423-5p | Q84218089 | ||
| Secreted monocytic miR-150 enhances targeted endothelial cell migration | Q84525686 | ||
| Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection | Q29618076 | ||
| MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb | Q29619411 | ||
| Shedding microvesicles: artefacts no more | Q29619416 | ||
| Functional delivery of viral miRNAs via exosomes | Q29619574 | ||
| Repression of protein synthesis by miRNAs: how many mechanisms? | Q29620361 | ||
| Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro | Q31090085 | ||
| Selective release of microRNA species from normal and malignant mammary epithelial cells | Q33728084 | ||
| Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma | Q33757859 | ||
| MicroRNAs add a new dimension to cardiovascular disease | Q33761132 | ||
| Reprogramming of miRNA networks in cancer and leukemia | Q33812540 | ||
| Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes | Q34127486 | ||
| Exosomes/microvesicles as a mechanism of cell-to-cell communication | Q34130853 | ||
| Functional MicroRNA Is Transferred between Glioma Cells | Q34137987 | ||
| Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia | Q34158366 | ||
| Microparticles in cardiovascular diseases. | Q34221054 | ||
| Membrane microparticles: two sides of the coin | Q34384910 | ||
| Plasma miR-208 as a biomarker of myocardial injury | Q34998594 | ||
| Exosomes biological significance: A concise review | Q36400139 | ||
| Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease | Q36519690 | ||
| Procoagulant microparticles: disrupting the vascular homeostasis equation? | Q36600785 | ||
| Emerging role of microRNAs in cardiovascular biology. | Q37026583 | ||
| The role of microparticles in the pathogenesis of rheumatic diseases. | Q37641758 | ||
| Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe? | Q37821167 | ||
| Signature microRNA expression profile of essential hypertension and its novel link to human cytomegalovirus infection | Q38489102 | ||
| Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection | Q39200565 | ||
| Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures | Q41394331 | ||
| Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans | Q41412919 | ||
| MicroRNA and mechanisms of impaired angiogenesis in diabetes mellitus | Q42922925 | ||
| Stability of endogenous and added RNA in blood specimens, serum, and plasma | Q44153103 | ||
| L1 penalized estimation in the Cox proportional hazards model | Q44515446 | ||
| Microparticles from ischemic muscle promotes postnatal vasculogenesis. | Q46006832 | ||
| Platelet microparticles enhance the vasoregenerative potential of angiogenic early outgrowth cells after vascular injury | Q46337618 | ||
| Hotline update of clinical trials and registries presented at the 77th spring meeting of the German Society of Cardiology 2011 | Q51165357 | ||
| Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study | Q51390729 | ||
| Exosome isolation for proteomic analyses and RNA profiling | Q51873711 | ||
| Proteomic analysis of secretory proteins and vesicles in vascular research | Q53474325 | ||
| Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. | Q54356342 | ||
| Analysis of circulating microRNA: preanalytical and analytical challenges. | Q54378210 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 2.5 Generic | Q19113746 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| cardiovascular disease | Q389735 | ||
| biomarker | Q864574 | ||
| gene regulatory network | Q1502576 | ||
| protein-lipid-RNA complex | Q22328923 | ||
| P304 | page(s) | 555-562 | |
| P577 | publication date | 2011-10-25 | |
| 2012-03-15 | |||
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | Profiling of circulating microRNAs: from single biomarkers to re-wired networks | |
| P478 | volume | 93 |
| Q48059089 | A polymorphism in the norepinephrine transporter gene is associated with affective and cardiovascular disease through a microRNA mechanism. |
| Q38314073 | A potentially functional polymorphism in the regulatory region of let-7a-2 is associated with an increased risk for diabetic nephropathy |
| Q30642656 | Aberrant phenotype in human endothelial cells of diabetic origin: implications for saphenous vein graft failure? |
| Q38962829 | Acute Response of Circulating Vascular Regulating MicroRNAs during and after High-Intensity and High-Volume Cycling in Children |
| Q46792665 | Analysis of circulating microRNAs that are specifically increased in hyperlipidemic and/or hyperglycemic sera |
| Q35122838 | Analysis of serum miRNA profiles of myasthenia gravis patients. |
| Q36959333 | Anomalous uptake and circulatory characteristics of the plant-based small RNA MIR2911 |
| Q90250082 | Assessment of six commercial plasma small RNA isolation kits using qRT-PCR and electrophoretic separation: higher recovery of microRNA following ultracentrifugation |
| Q37341170 | Association of MicroRNAs and YRNAs With Platelet Function |
| Q83485972 | Beyond nutrients: Food‐derived microRNAs provide cross‐kingdom regulation |
| Q41447406 | CRISPR/Cas9 editing reveals novel mechanisms of clustered microRNA regulation and function |
| Q37209930 | Circulating Organ-Specific MicroRNAs Serve as Biomarkers in Organ-Specific Diseases: Implications for Organ Allo- and Xeno-Transplantation |
| Q39413926 | Circulating exosomes in obstructive sleep apnea as phenotypic biomarkers and mechanistic messengers of end-organ morbidity |
| Q37310442 | Circulating levels of miR-133a predict the regression potential of left ventricular hypertrophy after valve replacement surgery in patients with aortic stenosis. |
| Q42364924 | Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes |
| Q34904013 | Circulating miRNA Biomarkers for Alzheimer's Disease |
| Q35162753 | Circulating miRNAs in ageing and ageing-related diseases |
| Q28728683 | Circulating microRNAs are not eliminated by hemodialysis |
| Q38459113 | Circulating microRNAs as Potential Biomarkers of Endothelial Dysfunction in Obese Children |
| Q38834809 | Circulating microRNAs as a Novel Class of Potential Diagnostic Biomarkers in Neuropsychiatric Disorders |
| Q27001706 | Circulating microRNAs as mirrors of acute coronary syndromes: MiRacle or quagMire? |
| Q37365013 | Circulating microRNAs have a sex-specific association with metabolic syndrome |
| Q38274805 | Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets |
| Q89598626 | Circulatory miR-133b and miR-21 as Novel Biomarkers in Early Prediction and Diagnosis of Coronary Artery Disease |
| Q37420502 | Clinical Significance of Determining Plasma MicroRNA33b in Type 2 Diabetic Patients with Dyslipidemia |
| Q35828512 | Comparison of a healthy miRNome with melanoma patient miRNomes: are microRNAs suitable serum biomarkers for cancer? |
| Q36739324 | Deep sequencing identifies circulating mouse miRNAs that are functionally implicated in manifestations of aging and responsive to calorie restriction |
| Q57342839 | Destination Known: Targeted Drug Delivery in Atherosclerosis and Thrombosis |
| Q42555901 | Diagnostic value of miR-30d-5p and miR-125b-5p in acute myocardial infarction |
| Q34599011 | Differential expression of circulating miRNAs in maternal plasma in pregnancies with fetal macrosomia |
| Q91894094 | Dysregulation of MicroRNA Regulatory Network in Lower Extremities Arterial Disease |
| Q36389315 | Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs |
| Q48175302 | Effect of chronic consumption of pistachios (Pistacia vera L.) on glucose metabolism in pre-diabetics and type 2 diabetics: A systematic review |
| Q38163830 | Electrochemical genosensors for the detection of cancer-related miRNAs. |
| Q34380487 | Exercise: putting action into our epigenome |
| Q36790311 | Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis |
| Q91277775 | Expression levels of circulating microRNAs-126, -155, and -145 in Mexican women exposed to polycyclic aromatic hydrocarbons through biomass fuel use |
| Q43188285 | From data gathering to systems medicine |
| Q37554078 | Function, Role, and Clinical Application of MicroRNAs in Vascular Aging |
| Q38160374 | Human RNAi pathway: crosstalk with organelles and cells |
| Q92074921 | Hypertension Associated With Hyperlipidemia Induced Different MicroRNA Expression Profiles in Plasma, Platelets, and Platelet-Derived Microvesicles; Effects of Endothelial Progenitor Cell Therapy |
| Q45793264 | Identification of microRNAs as potential cellular monocytic biomarkers in the early phase of myocardial infarction: a pilot study |
| Q34328997 | Is human cytomegalovirus infection associated with hypertension? The United States National Health and Nutrition Examination Survey 1999-2002 |
| Q38813514 | Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease? |
| Q43066865 | Low-Frequency Pulsed Electromagnetic Field Is Able to Modulate miRNAs in an Experimental Cell Model of Alzheimer's Disease |
| Q27027950 | Methodological challenges in utilizing miRNAs as circulating biomarkers |
| Q35814698 | MiR-486 and miR-92a Identified in Circulating HDL Discriminate between Stable and Vulnerable Coronary Artery Disease Patients. |
| Q38937055 | Micro RNAs: an arguable appraisal in medicine. |
| Q41663220 | MicroRNA Signaling in Embryo Development. |
| Q89528585 | MicroRNA and Cardiovascular Diseases |
| Q35114995 | MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease |
| Q26866000 | MicroRNAs Are Involved in End-Organ Damage During Hypertension |
| Q97568225 | MicroRNAs Regulated by the LPS/TLR2 Immune Axis as Bona Fide Biomarkers for Diagnosis of Acute Leptospirosis |
| Q33877294 | MicroRNAs are potential therapeutic targets in fibrosing kidney disease: lessons from animal models |
| Q38205084 | MicroRNAs as biomarkers in pituitary tumors. |
| Q91762118 | MicroRNAs as biomarkers of diabetic retinopathy and disease progression |
| Q38809666 | MicroRNAs as circulating biomarkers in acute coronary syndromes: A review |
| Q34031213 | MicroRNAs as lung cancer biomarkers |
| Q37211825 | MicroRNAs as novel therapeutic targets to treat kidney injury and fibrosis |
| Q27026545 | MicroRNAs as potential therapeutic targets in kidney disease |
| Q27002171 | MicroRNAs in Diabetic Kidney Disease |
| Q38012180 | Microparticles, not only markers but also a therapeutic target in the early stage of diabetic retinopathy and vascular aging |
| Q33635886 | Minireview: MIRomics in Endocrinology: A Novel Approach for Modeling Endocrine Diseases |
| Q38134570 | Moving RNA moves RNA forward |
| Q28081466 | Noncoding RNA in age-related cardiovascular diseases |
| Q26765463 | Nutrigenetics and Nutrimiromics of the Circadian System: The Time for Human Health |
| Q33754800 | NutrimiRAging: Micromanaging Nutrient Sensing Pathways through Nutrition to Promote Healthy Aging |
| Q51328676 | Platelet RNA as a novel biomarker for the response to antiplatelet therapy. |
| Q58096370 | Platelet microRNAs in hypertensive patients with and without cardiovascular disease |
| Q35120246 | Prognostic value of circulating microRNA-210 levels in patients with moderate to severe aortic stenosis |
| Q26739721 | Prospective and therapeutic screening value of non-coding RNA as biomarkers in cardiovascular disease |
| Q36142332 | RNY-derived small RNAs as a signature of coronary artery disease |
| Q33797472 | Relationship between microRNA-146a expression and plasma renalase levels in hemodialyzed patients |
| Q38230799 | Relevance of microRNA in metabolic diseases. |
| Q83410178 | Review focus on the role of microRNA in cardiovascular biology and disease |
| Q90432999 | Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders |
| Q86287891 | Saliva Supernatant miR-21: a Novel Potential Biomarker for Esophageal Cancer Detection |
| Q51456328 | Separation of Circulating MicroRNAs Using Apheresis in Patients With Systemic Lupus Erythematosus |
| Q36339333 | Serum non-coding RNAs as biomarkers for osteoarthritis progression after ACL injury |
| Q92934573 | Sex Differences in Plasma MicroRNA Biomarkers of Early and Complicated Diabetes Mellitus in Israeli Arab and Jewish Patients |
| Q35067334 | Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease |
| Q98177466 | Small Things Matter: Relevance of MicroRNAs in Cardiovascular Disease |
| Q36303108 | Systems Proteomics for Translational Network Medicine |
| Q52608599 | The Potential Role of Platelet-Related microRNAs in the Development of Cardiovascular Events in High-Risk Populations, Including Diabetic Patients: A Review. |
| Q38578754 | The RNA world in the 21st century-a systems approach to finding non-coding keys to clinical questions. |
| Q38624868 | The diagnostic and prognostic potential of plasma extracellular vesicles for cardiovascular disease |
| Q33359407 | The emerging role of non-coding RNA in essential hypertension and blood pressure regulation. |
| Q91396889 | The role of endothelial miRNAs in myocardial biology and disease |
| Q53124136 | The transcardiac gradient of cardio-microRNAs in the failing heart. |
| Q38296132 | Toward biosensors for the detection of circulating microRNA as a cancer biomarker: an overview of the challenges and successes. |
| Q52886738 | Translating the microRNA signature of microvesicles derived from human coronary artery smooth muscle cells in patients with familial hypercholesterolemia and coronary artery disease. |
| Q41359989 | Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases |
| Q42148804 | Validation of a multiplex reverse transcription and pre-amplification method using TaqMan(®) MicroRNA assays. |
| Q36164325 | Whole blood-derived microRNA signatures in mice exposed to lipopolysaccharides |
| Q31089306 | miR-421 and miR-30c inhibit SERPINE 1 gene expression in human endothelial cells |
| Q89019543 | miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges |
| Q26771724 | miRNAs Regulation and Its Role as Biomarkers in Endometriosis |
| Q26853511 | miRNAs in cardiac disease: sitting duck or moving target? |
| Q50219487 | miRNAs in cerebrospinal fluid identify patients with MS and specifically those with lipid-specific oligoclonal IgM bands |
| Q38668261 | microRNAs in Diabetic Kidney Disease |
| Q33362101 | microRNAs in Essential Hypertension and Blood Pressure Regulation |
| Q38375953 | microRNAs with different functions and roles in disease development and as potential biomarkers of diabetes: progress and challenges |
Search more.